RAINBOW Rainbow Childrens Medicare Q3 FY26 results (Oct–Dec 2025) and concall
Rainbow Children's Medicare delivered steady financial performance in Q3 FY26 despite a 'muted' seasonal illness cycle that typically drives higher volumes. The company is transitioning from a heavy capacity-addition phase (780 beds added in two years) to an execution phase focused on operational excellence and occupancy improvement. Management remains confident in achieving a 17-18% revenue CAGR over a four-year period, supported by the ramp-up of new units and a focus on high-end quaternary care like pediatric liver transplants.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 11.8%, net profit up 7.2% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 417 | 398 | 370 | 353 | 445 +7% | 445 +12% |
| EBITDA | 147 | 134 | 115 | 104 | 149 +1% | 147 +10% |
| Net profit | 79 | 69 | 57 | 54 | 76 −4% | 74 +7% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
